Introducing Pathogen Reduction Technology in Poland: A Cost-Utility Analysis.

Agapova, Maria; Lachert, Elzbieta; Brojer, Ewa; Letowska, Magdalena; Grabarczyk, Piotr; Custer, Brian

Agapova, Maria; Lachert, Elzbieta; Brojer, Ewa; Letowska, Magdalena; Grabarczyk, Piotr; Custer, Brian.

Afiliação

Agapova M; Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, WA, USA.
Lachert E; Institute of Haematology and Transfusion Medicine, Warsaw, Poland.
Brojer E; Institute of Haematology and Transfusion Medicine, Warsaw, Poland.
Letowska M; Institute of Haematology and Transfusion Medicine, Warsaw, Poland.
Grabarczyk P; Institute of Haematology and Transfusion Medicine, Warsaw, Poland.
Custer B; Blood Systems Research Institute, San Francisco, CA, USA ; Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA.

Transfus Med Hemother ; 42(3): 158-65, 2015 May.

Article em En | MEDLINE | ID: mdl-26195929

Palavras-chave

Blood safety; Cost-effectiveness; ICER; Mirasol PRT; Pathogen reduction technology; Poland

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Health_economic_evaluation / Prognostic_studies Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google